News Trending

1 Billion Covid-19 vaccines to be received by EU in end of September

By 494 0

The EU is on track to receive enough Covid-19 vaccination doses by the end of July to inoculate 70 per cent of its adult population, and the member states can join its travel certificate system from mid-June, the European Commission has announced.


Delivery estimates released to EU leaders as they convened in Brussels showed the bloc was on course by the end of September, to receive more than a billion doses of Covid-19 vaccines more than enough to fully vaccinate its population of 446 million.

In a joint conclusions the 27 national leaders noted that vaccination campaigns had “accelerated across the EU” and that this would “allow for a gradual reopening of our societies”.
46 per cent of the eligible EU population will have received at least one dose of a vaccine, by the end of May, as per the figures from European Commission president Ursula von der Leyen, she said, expected a decision by the European Medicines Agency on whether to clear the BioNTech-Pfizer vaccine in use for 12-15-year-olds soon.

Pic Courtesy: google/ images are subject to copyright

News

Russia Covid-19 vaccine in right direction, claims Russian scientists

By 709 0

In a report published in a renowned International journal, Russian scientists have announced their happiness in the success of their Covid-19 vaccine.

They have shared the details of the preliminary trials of their coronavirus vaccine to back the claim they have made.

The reports shows clearly that there are clear signs of an immune response.

It says that every participant of the preliminary test has developed antibodies to fight the virus.

As a clear indication that the vaccine can clearly dismiss all concerns raised against it, the report explains that the vaccine has no serious side effect.

The European country of Russia, which denounced the warning raised against the vaccine by the WHO and several other countries, already licensed the vaccine for local use, becoming the first country to approve a vaccine to fight against the crisis.

Anyway, the argument that the trial is too small to prove effectiveness and safety still holds water.

To remove the clouds around the effectiveness of the vaccine, the country at first have to address the aforesaid argument in a right manner.

It is hoped that a vaccine which is capable to address this issue in a right way reaches the market as early as possible.

Photo Courtesy: Google/ images are subject to copyright